These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2277306)

  • 1. 15-Deoxyspergualin and primate heart transplantation.
    Kapelanski DP; Perelman MJ; Faber LA; Paez DE; Rose EF; Behrendt DM
    J Heart Transplant; 1990; 9(6):668-73; discussion 673-4. PubMed ID: 2277306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimalization of immunosuppression after xenogeneic heart transplantation in primates.
    Reichenspurner H; Human PA; Boehm DH; Rose AG; May R; Cooper DK; Zilla P; Reichart B
    J Heart Transplant; 1989; 8(3):200-7; discussion 207-8. PubMed ID: 2661769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cyclosporine and 15-deoxyspergualin on coronary arteriosclerosis after heart transplantation in the rat.
    Nagamine S; Ohmi M; Tabayashi K; Iguchi A; Mohri H
    J Heart Lung Transplant; 1994; 13(5):895-8. PubMed ID: 7803433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunopharmacology of immunosuppression by 15-deoxyspergualin.
    Yuh DD; Morris RE
    Transplantation; 1993 Mar; 55(3):578-91. PubMed ID: 7681226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monotherapy with LF 15-0195, an analogue of 15-deoxyspergualin, significantly prolongs renal allograft survival in monkeys.
    Yang H; Chen G; Kanai N; Shum J; Garcia B; Huang X; Min W; Luo Y; Dutartre P; Zhong R
    Transplantation; 2003 Apr; 75(8):1166-71. PubMed ID: 12717197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a new immunosuppressant, 15-deoxyspergualin, on heterotopic rat heart transplantation, in comparison with cyclosporine.
    Suzuki S; Kanashiro M; Amemiya H
    Transplantation; 1987 Oct; 44(4):483-7. PubMed ID: 3313835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive effect of deoxyspergualin on acute renal allograft rejection in dogs.
    Fukao K; Otsuka M; Iwasaki H; Yuzawa K; Iwasaki Y
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1090-3. PubMed ID: 2650068
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of a novel immunosuppressive agent, deoxyspergualin, on rejection in kidney transplant recipients.
    Takahashi K; Ota K; Tanabe K; Oba S; Teraoka S; Toma H; Agishi T; Kawaguchi H; Ito K
    Transplant Proc; 1990 Aug; 22(4):1606-12. PubMed ID: 2389420
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolonged survival of musculoskeletal xenografts with combined cyclosporine and 15-deoxyspergualin.
    Tanabe YN; Randolph MA; Shimizu A; Butler PE; Lee WP
    Plast Reconstr Surg; 2000 Apr; 105(5):1695-703. PubMed ID: 10809100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of gender on allograft rejection in a rat heart transplant model.
    Takami H; Backer CL; Crawford SE; Zales VR; Mavroudis C
    J Heart Lung Transplant; 1995; 14(3):529-36. PubMed ID: 7654736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longer survival of rat limb allograft. Combined immunosuppression of FK-506 and 15-deoxyspergualin.
    Muramatsu K; Doi K; Akino T; Shigetomi M; Kawai S
    Acta Orthop Scand; 1997 Dec; 68(6):581-5. PubMed ID: 9462361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative studies on the immunosuppressive activity of FK506, 15-deoxyspergualin, and cyclosporine.
    Ochiai T; Nakajima K; Sakamoto K; Nagata M; Gunji Y; Asano T; Isono K; Sakamaki T; Hamaguchi K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):829-32. PubMed ID: 2468228
    [No Abstract]   [Full Text] [Related]  

  • 14. Synergistic effect of 15-deoxyspergualin and cyclosporine in prolonging survival of rat cardiac allografts.
    Kaji H; Chou DT; Sutherland DE; Stephanian E; Gores PF
    Transplant Proc; 1994 Apr; 26(2):869-70. PubMed ID: 8171689
    [No Abstract]   [Full Text] [Related]  

  • 15. 15-Deoxyspergualin is a more potent and effective immunosuppressant than cyclosporine but does not effectively suppress lymphoproliferation in vivo.
    Yuh DD; Morris RE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):535-9. PubMed ID: 1990605
    [No Abstract]   [Full Text] [Related]  

  • 16. Prophylactic deoxyspergualin treatment in living-related renal-transplant recipients transfused with donor-specific blood.
    Amada N; Okazaki H; Sato T; Miura S; Ohashi Y
    Transplantation; 2003 Jan; 75(1):60-6. PubMed ID: 12544872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of deoxyspergualin on vascular rejection in canine kidney transplantation.
    Tanabe K; Takahashi K; Nemoto K; Okada M; Yasuo M; Hayasaka Y; Toma H; Ota K
    J Urol; 1994 Aug; 152(2 Pt 1):562-6. PubMed ID: 8015112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolongation of islet and pancreas graft survival in spontaneous diabetic BB/W rats by perioperative cyclosporin or 15-deoxyspergualin therapy.
    von Specht BU; Dibelius A; Königsberger H; Lodde G; Roth H; Permanetter W
    Transplant Proc; 1989 Feb; 21(1 Pt 1):965-7. PubMed ID: 2495636
    [No Abstract]   [Full Text] [Related]  

  • 19. 15-Deoxyspergualin potentiates the immunosuppressive effect of cyclosporine A in a rat heart allograft model.
    Gannedahl G; Wanders A; Carlsson M; Tufveson G
    Transplant Proc; 1993 Feb; 25(1 Pt 1):768-9. PubMed ID: 8438473
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversibility of cardiac xenograft rejection in primates.
    McManus RP; Kinney T; Komorowski R; Hunter J
    J Heart Lung Transplant; 1991; 10(4):567-76. PubMed ID: 1911800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.